---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-017198"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T14:43:56.446880+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CEO Ryan Saadi contributes $500,000 to Tevogen Bio for new HQ costs

## Summary
- Founder and CEO Ryan Saadi contributed $500,000 cash to Tevogen Bio on June 30, 2025.
- Contribution earmarked for build-out and first-year operating costs of new Warren, NJ headquarters.
- CEO personally funding corporate infrastructure expansion, signaling insider commitment.

## SEC filing metadata
- accession: 0001641172-25-017198
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000164117225017198/0001641172-25-017198-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000164117225017198/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-017198
- JSON: https://secwatch.observer/filing/0001641172-25-017198.json
- Plain text: https://secwatch.observer/filing/0001641172-25-017198.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.